MENU
News
CME
Journals
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Infectious Disease
All Subspecialties
All Subspecialties
Antimicrobials
Dermatology
Emerging Diseases
Gastrointestinal Infections
Hepatitis C
HIV/AIDS
Influenza
MRSA
Nosocomial Infections
Pediatric ID
Practice Management
Respiratory Infections
STDs
Vaccination
Zoonotic Infections
More
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Account
Log Out
Log In
News
Search
News
CME
Journals
Log In
Log Out
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
All Subspecialties
All Subspecialties
Antimicrobials
Dermatology
Emerging Diseases
Gastrointestinal Infections
Hepatitis C
HIV/AIDS
Influenza
MRSA
Nosocomial Infections
Pediatric ID
Practice Management
Respiratory Infections
STDs
Vaccination
Zoonotic Infections
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Search
Healio
News
Infectious Disease
Current Issues
VIEW ISSUE
Infectious Disease News
Recently Posted
In midst of COVID-19, US sees ‘unusually low’ flu activity
Anaphylaxis rarely reported among first 4 million doses of Moderna vaccine
Around 20% of people in US have an STI, CDC finds
VIEW ISSUE
Infectious Diseases in Children
Recently Posted
Pediatric telehealth gets ‘trial by fire’ during COVID-19 pandemic
Smithsonian, WHO launch interactive COVID-19 guide for kids
Should telehealth appointments cost the same as in-person visits?
VIEW ISSUE
HCV Next
Recently Posted
HCV Next in Retrospect: Looking Back at ‘Your Guide to the Age After Interferon’
Gilead announces launch of Epclusa, Harvoni generics for HCV
HCV: The End of the Evolution, the Beginning of the Social Science